BD patients | BD serum samples | |
---|---|---|
Males/females | 12/15 | 27/30 |
Age (mean ± SD), years | 45.7±13.54 | 51.19±30.26 |
Disease onset (mean ± SD), years | 32.55±14.35 | 34.15±13.48 |
Disease duration (mean ± SD), years | 13.59±12.67 | 13.85±12.34 |
HLA-B51 positivity. n (%) | 17 (62.96) | 40 (70.17) |
Oral/genital aphtosis | 23 (85.18) | 39 (68.42) |
Skin manifestations | 10 (37.03) | 12 (21.05) |
Uveitis | 11 (40.74) | 20 (35.08) |
SNC involvement | 18 (66.66) | 26 (45.61) |
Vascular involvement | 2 (7.40) | 4 (07.01) |
Gastrointestinal manifestations | 4 (14.81) | 4 (07.01) |
Musculoskeletal involvement | 20 (74.07) | 27 (47.36) |